Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
07/2001
07/19/2001US20010008901 Nitrile derivatives that inhibit cathepsin K
07/19/2001US20010008890 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
07/19/2001DE10039723A1 New heterocyclylalkoxy-substituted benzoyl ketone derivatives are herbicides useful as defoliants, desiccants and especially weedkillers
07/19/2001DE10000892A1 New 4-(1-(hydroxy or 2,2,6,6-tetramethyl-piperidin-1-yloxy)-alkyl)-py rrolidine derivatives, having biological, especially neuro-physiological, activity, useful as drugs or pesticides
07/19/2001CA2397575A1 Antibacterial agents
07/18/2001EP1116716A1 Piperidine and piperazine compounds for use in the treatment of Alzheimer
07/18/2001EP1116715A1 Tetramic acid derivatives useful in medicines and foodstuffs
07/18/2001EP1116711A2 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds
07/18/2001EP1115758A2 Polymerization of olefins
07/18/2001EP1115741A2 Stereoselective process for enalapril
07/18/2001EP1115703A1 Cyclic ester or amide derivatives
07/18/2001EP1115702A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof
07/18/2001EP1115697A1 Unsaturated hydroximic acid derivatives as parp inhibitors
07/18/2001EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
07/18/2001EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
07/18/2001EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/18/2001EP0721446B1 Chiral surfactants and methods for their use in chiral separations
07/18/2001CN1304447A Treatment of parasitic diseases by inhibition of cysteine proteases of papain superfamily
07/18/2001CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
07/18/2001CN1304392A Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
07/18/2001CN1303851A Synthesis method of idocifen
07/18/2001CN1068583C N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
07/17/2001US6262306 Materials with ferromagnetic properties comprising organic molecules with magnetic properties, and methods for making same
07/17/2001US6262206 Polymerizable compositions containing alkoxyamine compounds derived from nitroso- or nitrone compounds
07/17/2001US6262101 Alpha-pyrrolidine, imidazole and thiophene-substituted styrene derivatives; inhibitors of tumor necrosis factor alpha, nuclear factor kappa b, and phosphodiesterase
07/17/2001US6262092 Mutual salt of amlodipine and atorvastatin
07/17/2001US6262090 Aminopyridine-containing thiourea inhibitors of herpes viruses
07/17/2001US6262089 Using these compounds to treat diseases associated with amyloidosis, such as alzheimer's disease, maturity onset diabetes mellitus, familial amyloid polyneuropathy, scrapie, and kreuzfeld-jacob disease.
07/17/2001US6262060 Treatment of hyperglycaemia, diabetes, obesity or inflammation
07/17/2001US6262044 Modulators of protein tyrosine phosphatases (PTPASES)
07/12/2001WO2001049674A2 Glycosidase inhibitors and preparation thereof
07/12/2001WO2001049664A1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
07/12/2001WO2001049288A1 Novel compounds and compositions as protease inhibitors
07/12/2001WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters
07/12/2001WO2001021604A8 Substituted piperazine derivatives, the production thereof and their use as inhibitors of the microsomal triglyceride-transfer protein (mtp)
07/12/2001WO2001002358A3 Cyclized amide derivatives for treating or preventing neuronal damage
07/12/2001US20010007764 Oligopeptides
07/12/2001DE19963174A1 Substituierte Pyrrol-Mannichbasen Substituted pyrrole Mannich bases
07/12/2001CA2396688A1 Glycosidase inhibitors and methods of synthesizing same
07/12/2001CA2396257A1 Novel compounds and compositions as protease inhibitors
07/12/2001CA2395267A1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
07/12/2001CA2394184A1 Methods and compositions for mitigating pain using nitrate esters
07/11/2001EP1114823A2 Substituted benzylamino nitrogen containing non-aromatic heterocycles
07/11/2001EP1114040A1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
07/11/2001EP1114029A1 Novel compounds
07/11/2001EP1114027A1 The preparation of n-substituted-hydroxycycloalkylamine derivatives
07/11/2001EP1113789A1 Method and composition for treatment of inflammatory bowel disease
07/11/2001EP0912509B1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
07/11/2001EP0823896B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
07/11/2001CN1303381A Dipeptidyl peptidase IV effectors
07/11/2001CN1303376A Compound with activity on muscarinic receptors
07/11/2001CN1303375A Aryl phenyl substituted cyclic ketoenols
07/11/2001CN1303364A Aminocyclohexyl ether compounds and uses thereof
07/11/2001CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity
07/11/2001CN1068325C Phenyloxazolidinone antimicrobials
07/11/2001CN1068308C Substituted benzoylguanide, its preparing process and medicine and application of same
07/10/2001US6258967 Reacting zinc halide with orgaometallic compounds
07/10/2001US6258959 Process for the preparation of 2,4-dimethyl-3,5-bisalkoxycarbonylpyrrole
07/10/2001US6258954 Fluorescent maleimides and uses thereof
07/10/2001US6258953 Arylacrylamide derivatives
07/10/2001US6258833 Enzyme inhibitors and antiinflammatory agents
07/10/2001US6258811 Methods for preventing, inhibiting or treating graft rejection reactions in graft-versus-host disease (GVHD) and organ transplantation
07/10/2001US6258805 Pyrroloazepine derivatives
07/10/2001US6258584 Drug screening for modulators of collagen formation by measuring enzyme activity in presence and absence of compound; reduced activity indicates enzyme inhibitor; antiarthritic agents; antiscarring agents
07/10/2001CA2175502C Cyclic amide derivatives
07/10/2001CA2089712C Mannich reaction product and process for producing the same and use of the product
07/05/2001WO2001047948A1 Novel dipeptide compound and medicinal use thereof
07/05/2001WO2001047905A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
07/05/2001WO2001047886A1 Nitrile derivatives as cathepsin k inhibitors
07/05/2001WO2001047881A1 Ascosalipyrrolone derivatives
07/05/2001WO2001047880A1 Cyclic amp-specific phosphodiesterase inhibitors
07/05/2001WO2001047879A1 Pyrrolidines which inhibit camp-specific pde
07/05/2001WO2001047878A1 Substituted pyrrole mannich bases to combat pain and allergic reactions
07/05/2001WO2001047868A1 Novel phenylalanine derivatives
07/05/2001WO2001047862A1 Optically active materials
07/05/2001WO2001047558A1 Nerve protective drugs
07/05/2001WO2000068195A3 Substituted pyrrolidines as cell adhesion inhibitors
07/05/2001US20010006975 Raf kinase inhibitors
07/05/2001US20010006619 Compounds for cancer imaging and therapy
07/05/2001CA2396502A1 Substituted pyrrole mannich bases
07/05/2001CA2395996A1 Neuroprotective drug
07/05/2001CA2395543A1 Cyclic amp-specific phosphodiesterase inhibitors
07/05/2001CA2395179A1 Nitrile derivatives as cathepsin k inhibitors
07/05/2001CA2395173A1 Pyrrolidines which inhibit camp-specific pde
07/05/2001CA2362849A1 Novel dipeptide compounds and their use as medicines
07/04/2001EP1113015A1 Optically active 3-((2-piperazinyl-phenyl)methyl)-1-(4-(trifluoromethyl)-phenyl)-2-pyrrolidinone compounds as 5-HT1D receptor selective antagonists
07/04/2001EP1113000A1 Benzene derivatives and medicinal use thereof
07/04/2001EP1112269A2 Hiv protease inhibitors
07/04/2001EP1112253A1 Branched alkyl pyrrolidine-3-carboxylic acids
07/04/2001EP1112252A1 Kappa agonist compounds and pharmaceutical formulations thereof
07/04/2001EP1112071A1 Growth hormone secretagogues
07/04/2001EP0830709B1 Electrolyte materials containing highly dissociated metal ion salts
07/04/2001EP0634927B1 Treatment and prophylaxis of diseases caused by parasites, or bacteria
07/04/2001EP0618810B1 Bradykinin antagonist peptides
07/03/2001US6255512 High energy oxidizing agents in explosive compositions, propellant formulations, gas-generating compositions, andpharmaceutical agents
07/03/2001US6255496 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
07/03/2001US6255342 Pesticides
07/03/2001US6255336 Amino ceramide-like compounds and therapeutic methods of use
07/03/2001US6255327 Diphenyl-substituted heterocycles, processes for preparing them and their use as pharmaceutical compositions
07/03/2001US6255301 Amino acid derivatives and their use as thrombin inhibitors